Concentration and purification of hydrophobins and antibodies with a phase separation method

Jussi Joensuu; Markus Linder; Eero Mustalahti; Katri Kurppa

Concentration and purification of hydrophobins and antibodies with a phase separation method

Jussi Joensuu (Inventor), Markus Linder (Inventor), Eero Mustalahti (Inventor), Katri Kurppa (Inventor)

Research output: Patent › Patent

Abstract

The present invention relates to a purification and concentration method for proteins and antibodies. Particularly the present invention relates to a continuous surfactant based phase separation method for recovering hydrophobin fusion proteins, and for recovering target molecules, such as antibodies, directly from a liquid by using phase separation and hydrophobin-Protein A fusion technologies.

Patent family as of 27.10.2021
DE602014074423 D1 20210211 DE201460074423T 20140701
EP3016966 A1 20160511 EP20140819723 20140701
EP3016966 A4 20170308 EP20140819723 20140701
EP3016966 B1 20210120 EP20140819723 20140701
FI127353 B 20180413 FI20130005750 20130705
FI20135750 A 20150106 FI20130005750 20130705
IN04211KN2015 A 20160701 IN2015KN04211 20151223
IN362135 B 20210326 IN2015KN04211 20151223
SG11201600040W A1 20160226 SG20161100040 20140701
US10266562 BB 20190423 US20140902851 20140701
US2016159854 AA 20160609 US20140902851 20140701
WO15001187 A1 20150108 WO2014FI50545 20140701

Link to current patent family on right

Original language	English
Patent number	EP3016966
IPC	C07K 14/ 37 A I
Priority date	1/07/14
Publication status	Published - 11 May 2016
MoE publication type	H1 Granted patent

Cite this

@misc{c81b5f3fadc54581b1fff1baa762ff8f,

title = "Concentration and purification of hydrophobins and antibodies with a phase separation method",

abstract = "The present invention relates to a purification and concentration method for proteins and antibodies. Particularly the present invention relates to a continuous surfactant based phase separation method for recovering hydrophobin fusion proteins, and for recovering target molecules, such as antibodies, directly from a liquid by using phase separation and hydrophobin-Protein A fusion technologies.Patent family as of 27.10.2021DE602014074423 D1 20210211 DE201460074423T 20140701 EP3016966 A1 20160511 EP20140819723 20140701 EP3016966 A4 20170308 EP20140819723 20140701 EP3016966 B1 20210120 EP20140819723 20140701 FI127353 B 20180413 FI20130005750 20130705 FI20135750 A 20150106 FI20130005750 20130705 IN04211KN2015 A 20160701 IN2015KN04211 20151223 IN362135 B 20210326 IN2015KN04211 20151223 SG11201600040W A1 20160226 SG20161100040 20140701 US10266562 BB 20190423 US20140902851 20140701 US2016159854 AA 20160609 US20140902851 20140701 WO15001187 A1 20150108 WO2014FI50545 20140701Link to current patent family on right ",

author = "Jussi Joensuu and Markus Linder and Eero Mustalahti and Katri Kurppa",

year = "2016",

month = may,

day = "11",

language = "English",

type = "Patent",

note = "EP3016966; C07K 14/ 37 A I",

}

TY - PAT

T1 - Concentration and purification of hydrophobins and antibodies with a phase separation method

AU - Joensuu, Jussi

AU - Linder, Markus

AU - Mustalahti, Eero

AU - Kurppa, Katri

PY - 2016/5/11

Y1 - 2016/5/11

N2 - The present invention relates to a purification and concentration method for proteins and antibodies. Particularly the present invention relates to a continuous surfactant based phase separation method for recovering hydrophobin fusion proteins, and for recovering target molecules, such as antibodies, directly from a liquid by using phase separation and hydrophobin-Protein A fusion technologies.Patent family as of 27.10.2021DE602014074423 D1 20210211 DE201460074423T 20140701 EP3016966 A1 20160511 EP20140819723 20140701 EP3016966 A4 20170308 EP20140819723 20140701 EP3016966 B1 20210120 EP20140819723 20140701 FI127353 B 20180413 FI20130005750 20130705 FI20135750 A 20150106 FI20130005750 20130705 IN04211KN2015 A 20160701 IN2015KN04211 20151223 IN362135 B 20210326 IN2015KN04211 20151223 SG11201600040W A1 20160226 SG20161100040 20140701 US10266562 BB 20190423 US20140902851 20140701 US2016159854 AA 20160609 US20140902851 20140701 WO15001187 A1 20150108 WO2014FI50545 20140701Link to current patent family on right

AB - The present invention relates to a purification and concentration method for proteins and antibodies. Particularly the present invention relates to a continuous surfactant based phase separation method for recovering hydrophobin fusion proteins, and for recovering target molecules, such as antibodies, directly from a liquid by using phase separation and hydrophobin-Protein A fusion technologies.Patent family as of 27.10.2021DE602014074423 D1 20210211 DE201460074423T 20140701 EP3016966 A1 20160511 EP20140819723 20140701 EP3016966 A4 20170308 EP20140819723 20140701 EP3016966 B1 20210120 EP20140819723 20140701 FI127353 B 20180413 FI20130005750 20130705 FI20135750 A 20150106 FI20130005750 20130705 IN04211KN2015 A 20160701 IN2015KN04211 20151223 IN362135 B 20210326 IN2015KN04211 20151223 SG11201600040W A1 20160226 SG20161100040 20140701 US10266562 BB 20190423 US20140902851 20140701 US2016159854 AA 20160609 US20140902851 20140701 WO15001187 A1 20150108 WO2014FI50545 20140701Link to current patent family on right

UR - https://worldwide.espacenet.com/patent/search/family/052143162/publication/EP3016966A1?q=EP3016966

M3 - Patent

M1 - EP3016966

ER -

Concentration and purification of hydrophobins and antibodies with a phase separation method

Abstract

Other files and links

Fingerprint

Cite this